February 28, 2023 — 08:38 am EST

      Written by
                        RTTNews.com for                             
        




RTTNews ->


(RTTNews) - Sutro Biopharma, Inc. (STRO), a clinical-stage oncology company, said on Tuesday that it has appointed Anne Borgman as Chief Medical Officer or CMO, with effect from February 28. 
Borgman succeeds Arturo Molina who resigned as CMO in November last year. 
Borgman has over two decades of oncology and hematology drug development and extensive regulatory experience in both the U.S. and Europe.
Previously, Dr. Borgman was Vice President, Clinical Research & Development, at Exelixis, Inc. 
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

© 2023, Nasdaq, Inc. All Rights Reserved.










To add symbols:


These symbols will be available throughout the site during your session.
To add symbols:


These symbols will be available throughout the site during your session.